W. Smith

W.
Bradford Smith is currently Chief Financial Officer at Incendia Therapeutics, Inc. since 2024.
He serves as Independent Director at eGenesis, Inc. since 2021 and at Lyra Therapeutics, Inc. since 2019.
Formerly, Mr. Smith was Treasurer, Chief Financial & Business Officer at Homology Medicines, Inc. from 2022 to 2023.
He was Chief Financial Officer at Ocular Therapeutix, Inc. from 2014 to 2017, OmniGuide, Inc. from 2008 to 2014, NeuroMetrix, Inc. from 2005 to 2008, Synexus Compass, Inc. from 2003 to 2005, PatientKeeper, Inc. from 2000 to 2003, and Focal, Inc. from 1993 to 2000.
He held the position of Chief Financial Officer at CytoTherapuetics, Inc. and was Senior Accountant at Coopers & Lybrand LLP.
Education includes an undergraduate degree from Tufts University in 1977 and an MBA from Peter T Paul College of Business & Economics in 1981.